Sofia Ajeganova

2.0k citations

49 papers · 1.3k indexed · h-index 22

Impact in

Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 42
- Systemic Lupus Erythematosus Research 32
- Rheumatoid Arthritis Research and Therapies 26
Immunology 20
- Atherosclerosis and Cardiovascular Diseases 14

Co-authors: Ingiäld Hafström (33 shared papers)T. Huizinga (11 shared papers)Johan Frostegård (18 shared papers)Maria Andersson (8 shared papers)Björn Svensson (14 shared papers)Annette H M van der Helm–van Mil (6 shared papers)Kristina Forslind (8 shared papers)H.W. van Steenbergen (3 shared papers)
Journals: Annals of the Rheumatic Diseases (8 papers)Arthritis Research & Therapy (7 papers)The Journal of Rheumatology (3 papers)Therapeutic Advances in Musculoskeletal Disease (2 papers)Scandinavian Journal of Rheumatology (2 papers)
Partner nations: Sweden Belgium Netherlands

In The Last Decade

Sofia Ajeganova

47 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sofia Ajeganova

Since Specialization

Citations

This map shows the geographic impact of Sofia Ajeganova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Ajeganova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Ajeganova more than expected).

Fields of papers citing papers by Sofia Ajeganova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Ajeganova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Ajeganova. The network helps show where Sofia Ajeganova may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofia Ajeganova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofia Ajeganova Line = papers co-authored together Sofia Ajeganova links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long‐term followup from disease onset Arthritis Care & Research ·Sofia Ajeganova, Maria Andersson, Ingiäld Hafström, (unknown)	2012	177
2	Late‐onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections Arthritis & Rheumatism ·Daniel Tesfa, Sofia Ajeganova, Hans Hägglund, Birgitta Sander, Bengt Fadeel, Ingiäld Hafström, Jan Palmblad	2011	109
3	Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations Therapeutic Advances in Musculoskeletal Disease ·Sofia Ajeganova, T. Huizinga	2017	100
4	Disease Factors in Early Rheumatoid Arthritis Are Associated with Differential Risks for Cardiovascular Events and Mortality Depending on Age at Onset: A 10-year Observational Cohort Study The Journal of Rheumatology ·Sofia Ajeganova, Maria Andersson, Johan Frostegård, Ingiäld Hafström	2013	78
5	The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor Annals of the Rheumatic Diseases ·Sofia Ajeganova, H.W. van Steenbergen, Marije K. Verheul, Kristina Forslind, Ingiäld Hafström, René E. M. Toes, T. Huizinga, Björn Svensson, Leendert A. Trouw, Annette H M van der Helm–van Mil	2016	67
6	Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts Annals of the Rheumatic Diseases ·Sofia Ajeganova, Jennifer Humphreys, Marije K. Verheul, H.W. van Steenbergen, Jessica A B van Nies, Ingiäld Hafström, B G Svensson, T. Huizinga, Leendert A. Trouw, Suzanne Verstappen, Annette H M van der Helm–van Mil	2016	61
7	Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms Annals of the Rheumatic Diseases ·Sofia Ajeganova, H.W. van Steenbergen, Jessica A B van Nies, L.E. Burgers, T. Huizinga, Annette H M van der Helm–van Mil	2015	60
8	Seronegative and seropositive RA: alike but different? Nature Reviews Rheumatology ·Sofia Ajeganova, T. Huizinga	2014	55
9	Carotid Atherosclerosis, Disease Measures, Oxidized Low-density Lipoproteins, and Atheroprotective Natural Antibodies for Cardiovascular Disease in Early Rheumatoid Arthritis — An Inception Cohort Study The Journal of Rheumatology ·Sofia Ajeganova, Ulf dé Fairé, Tomas Jogestrand, Johan Frostegård, Ingiäld Hafström	2012	54
10	Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study Arthritis Research & Therapy ·Tineke J van Wesemael, Sofia Ajeganova, Jennifer Humphreys, Chikashi Terao, Ammar Muhammad, Deborah Symmons, Alex J. MacGregor, Ingiäld Hafström, Leendert A. Trouw, Annette H M van der Helm–van Mil, T. Huizinga, Tsuneyo Mimori, René E. M. Toes, Fumihiko Matsuda, Björn Svensson, Suzanne Verstappen, Diane van der Woude	2016	48
11	Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years Lupus Science & Medicine ·Sofia Ajeganova, Ingiäld Hafström, Johan Frostegård	2021	43
12	Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial BMJ Open ·Sofia Ajeganova, Björn Svensson, Ingiäld Hafström, (unknown)	2014	42
13	Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present Annals of the Rheumatic Diseases ·V. Derksen, Sofia Ajeganova, Leendert A. Trouw, Annette H M van der Helm–van Mil, Ingiäld Hafström, T. Huizinga, René E. M. Toes, Björn Svensson, Diane van der Woude	2016	37
14	Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis Open Access Rheumatology Research and Reviews ·Jenny Nilsson, Maria Andersson, Ingiäld Hafström, Björn Svensson, Kristina Forslind, Sofia Ajeganova, Monica Leu Agelii, Inger Gjertsson	2021	35
15	IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors Atherosclerosis ·Jitong Sun, Susanna L. Lundström, Bo Zhang, Roman A. Zubarev, Johnny Steuer, Peter Gillgren, Mizanur Rahman, Sofia Ajeganova, Anquan Liu, Johan Frostegård	2017	35
16	Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus Lupus ·Anquan Liu, Mizanur Rahman, Ingiäld Hafström, Sofia Ajeganova, Johan Frostegård	2020	27
17	Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms Arthritis Research & Therapy ·Johan Frostegård, Sabbir Ahmed, Ingiäld Hafström, Sofia Ajeganova, Mizanur Rahman	2021	25
18	Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study Arthritis Research & Therapy ·Sofia Ajeganova, Thomas Gustafsson, Tomas Jogestrand, Johan Frostegård, Ingiäld Hafström	2015	24
19	Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study. PubMed ·Sofia Ajeganova, Roland Fiskesund, de Faire U, Ingiäld Hafström, Johan Frostegård	2012	24
20	Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients Lupus Science & Medicine ·Sofia Ajeganova, Thomas Gustafsson, Linnea Lindberg, Ingiäld Hafström, Johan Frostegård	2020	24

About Sofia Ajeganova

Sofia Ajeganova is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (32 papers), Rheumatoid Arthritis Research and Therapies (26 papers), Atherosclerosis and Cardiovascular Diseases (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Viral Infections and Immunology Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Rheumatology (984 citations), Hematology (221 citations), Immunology (352 citations), Genetics (139 citations) and Radiology, Nuclear Medicine and Imaging (200 citations). Sofia Ajeganova has collaborated with scholars based in Sweden, Belgium and Netherlands. Frequent co-authors include Ingiäld Hafström, T. Huizinga, Johan Frostegård, Maria Andersson, Björn Svensson, Annette H M van der Helm–van Mil, Kristina Forslind, H.W. van Steenbergen, Leendert A. Trouw and Tomas Jogestrand. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy, The Journal of Rheumatology, Therapeutic Advances in Musculoskeletal Disease and Scandinavian Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact